Reduction in the sensitivity to the peripheral and central actions of insulin (insulin resistance) is associated with several of the most frequent and prevalent human disorders, including type 2 diabetes mellitus, obesity and dyslipidemia [1], [2]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.